Trevena Inc (TRVN)
1.69
-0.06
(-3.43%)
USD |
OTCM |
Nov 04, 16:00
Trevena Enterprise Value: 16.60M for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 16.60M |
| November 01, 2024 | 16.65M |
| October 31, 2024 | 16.81M |
| October 30, 2024 | 16.85M |
| October 29, 2024 | 16.86M |
| October 28, 2024 | 16.93M |
| October 25, 2024 | 16.86M |
| October 24, 2024 | 17.04M |
| October 23, 2024 | 16.75M |
| October 22, 2024 | 16.86M |
| October 21, 2024 | 16.80M |
| October 18, 2024 | 16.81M |
| October 17, 2024 | 16.87M |
| October 16, 2024 | 17.16M |
| October 15, 2024 | 16.98M |
| October 14, 2024 | 16.85M |
| October 11, 2024 | 16.83M |
| October 10, 2024 | 16.54M |
| October 09, 2024 | 16.41M |
| October 08, 2024 | 16.41M |
| October 07, 2024 | 17.29M |
| October 04, 2024 | 19.09M |
| October 03, 2024 | 18.57M |
| October 02, 2024 | 18.36M |
| October 01, 2024 | 18.52M |
| Date | Value |
|---|---|
| September 30, 2024 | 18.35M |
| September 27, 2024 | 18.55M |
| September 26, 2024 | 18.48M |
| September 25, 2024 | 18.49M |
| September 24, 2024 | 18.58M |
| September 23, 2024 | 18.32M |
| September 20, 2024 | 18.58M |
| September 19, 2024 | 19.17M |
| September 18, 2024 | 19.33M |
| September 17, 2024 | 19.38M |
| September 16, 2024 | 18.96M |
| September 13, 2024 | 20.23M |
| September 12, 2024 | 20.87M |
| September 11, 2024 | 21.55M |
| September 10, 2024 | 21.85M |
| September 09, 2024 | 19.51M |
| September 06, 2024 | 18.56M |
| September 05, 2024 | 18.68M |
| September 04, 2024 | 18.67M |
| September 03, 2024 | 18.66M |
| August 30, 2024 | 18.52M |
| August 29, 2024 | 18.57M |
| August 28, 2024 | 18.76M |
| August 27, 2024 | 19.07M |
| August 26, 2024 | 18.81M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-19.71M
Minimum
Mar 24 2023
411.95M
Maximum
Sep 29 2020
69.16M
Average
19.09M
Median
Oct 04 2024
Enterprise Value Benchmarks
| Pfizer Inc | 219.16B |
| United Therapeutics Corp | 13.90B |
| Syndax Pharmaceuticals Inc | 1.179B |
| Arcus Biosciences Inc | 453.61M |
| NovaBay Pharmaceuticals Inc | 3.645M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.891M |
| Revenue (Quarterly) | 0.325M |
| Total Expenses (Quarterly) | 6.828M |
| EPS Diluted (Quarterly) | -5.75 |
| Gross Profit Margin (Quarterly) | 68.31% |
| Profit Margin (Quarterly) | -1.50K% |
| Earnings Yield | -3.39K% |
| Normalized Earnings Yield | -3705.22 |